Literature DB >> 22534474

Assessment of BRAF and KIT mutations in Japanese melanoma patients.

Atsuko Ashida, Hisashi Uhara, Yukiko Kiniwa, Misae Oguchi, Hiroshi Murata, Yasufumi Goto, Aya Uchiyama, Eisaku Ogawa, Koichi Hayashi, Hiroshi Koga, Ryuhei Okuyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22534474     DOI： 10.1016/j.jdermsci.2012.03.005

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN： 0923-1811            Impact factor:   4.563


× No keyword cloud information.
  9 in total

Review 1.  Improving the diagnosis and treatment of acral melanocytic lesions.

Authors:  Maressa C Criscito; Jennifer A Stein
Journal:  Melanoma Manag       Date:  2017-05-19

2.  Mutation Profile of B-Raf Gene Analyzed by fully Automated System and Clinical Features in Japanese Melanoma Patients.

Authors:  Masaru Ide; Shinichi Koba; Naoko Sueoka-Aragane; Akemi Sato; Yuri Nagano; Takuya Inoue; Noriyuki Misago; Yutaka Narisawa; Shinya Kimura; Eisaburo Sueoka
Journal:  Pathol Oncol Res       Date:  2016-10-21       Impact factor: 3.201

3.  NRAS mutations in primary and metastatic melanomas of Japanese patients.

Authors:  Hisashi Uhara; Atsuko Ashida; Hiroshi Koga; Eisaku Ogawa; Aya Uchiyama; Ryuhei Uchiyama; Koichi Hayashi; Yukiko Kiniwa; Ryuhei Okuyama
Journal:  Int J Clin Oncol       Date:  2013-06-06       Impact factor: 3.402

4.  Quantitative analysis of the BRAF V600E mutation in circulating tumor-derived DNA in melanoma patients using competitive allele-specific TaqMan PCR.

Authors:  Atsuko Ashida; Kaori Sakaizawa; Asuka Mikoshiba; Hisashi Uhara; Ryuhei Okuyama
Journal:  Int J Clin Oncol       Date:  2016-04-04       Impact factor: 3.402

5.  Long-term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma.

Authors:  Naoya Yamazaki; Yoshio Kiyohara; Hisashi Uhara; Jiro Uehara; Yasuhiro Fujisawa; Tatsuya Takenouchi; Masaki Otsuka; Hiroshi Uchi; Hironobu Ihn; Masahiro Hatsumichi; Hironobu Minami
Journal:  Cancer Sci       Date:  2019-05-23       Impact factor: 6.716

6.  Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation.

Authors:  Yukiko Kiniwa; Kenta Nakamura; Asuka Mikoshiba; Atsuko Ashida; Yasuyuki Akiyama; Atsushi Morimoto; Ryuhei Okuyama
Journal:  BMC Cancer       Date:  2021-03-17       Impact factor: 4.430

7.  Prognostic and Clinicopathologic Associations of BRAF Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study.

Authors:  Jin-Woo Hong; Suee Lee; Dae-Cheol Kim; Ki-Ho Kim; Ki-Hoon Song
Journal:  Ann Dermatol       Date:  2014-04-30       Impact factor: 1.444

8.  Phase 1/2 study assessing the safety and efficacy of dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced cutaneous melanoma.

Authors:  Naoya Yamazaki; Arata Tsutsumida; Akira Takahashi; Kenjiro Namikawa; Shusuke Yoshikawa; Yutaka Fujiwara; Shunsuke Kondo; Akihira Mukaiyama; Fanghong Zhang; Yoshio Kiyohara
Journal:  J Dermatol       Date:  2018-02-05       Impact factor: 4.005

9.  Characterizations of Gene Alterations in Melanoma Patients from Chinese Population.

Authors:  Yi Luo; Zhenzhen Zhang; Jianfan Liu; Linqing Li; Xuezheng Xu; Xinyu Yao; Zixun Dai; Xin Wang; Shuo Yang; Hongwei Wu; Jie Bu; Yuan Wu; Tianmin Xiang; Xianan Li
Journal:  Biomed Res Int       Date:  2020-01-30       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.